Outset Medical Operating Income 2019-2023 | OM

Outset Medical operating income from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Outset Medical Annual Operating Income
(Millions of US $)
2023 $-170
2022 $-161
2021 $-131
2020 $-117
2019 $-70
2018 $-47
Outset Medical Quarterly Operating Income
(Millions of US $)
2023-12-31 $-37
2023-09-30 $-45
2023-06-30 $-43
2023-03-31 $-43
2022-12-31 $-40
2022-09-30 $-41
2022-06-30 $-44
2022-03-31 $-36
2021-12-31 $-41
2021-09-30 $-30
2021-06-30 $-30
2021-03-31 $-30
2020-12-31 $-32
2020-09-30 $-41
2020-06-30 $-25
2020-03-31 $-20
2019-12-31
2019-09-30 $-18
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.182B $0.130B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.115B 20.38
Inspire Medical Systems (INSP) United States $4.725B 0.00
Axonics (AXNX) United States $3.452B 0.00
IRhythm Technologies (IRTC) United States $3.070B 0.00
10x Genomics (TXG) United States $3.049B 0.00
Hims & Hers Health (HIMS) United States $3.016B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.978B 0.00
Enovis (ENOV) United States $2.863B 21.22
Azenta (AZTA) United States $2.768B 155.58
Privia Health (PRVA) United States $2.028B 113.33
Schrodinger (SDGR) United States $1.664B 0.00
Omnicell (OMCL) United States $1.454B 50.25
Phreesia (PHR) United States $1.379B 0.00
Standard BioTools (LAB) United States $0.725B 0.00
Fulgent Genetics (FLGT) United States $0.673B 0.00
Definitive Healthcare (DH) United States $0.649B 0.00
Talkspace (TALK) United States $0.475B 0.00
Clover Health Investments (CLOV) United States $0.464B 0.00
Health Catalyst (HCAT) United States $0.415B 0.00
Pulmonx (LUNG) United States $0.351B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.301B 0.00
Butterfly Network (BFLY) United States $0.213B 0.00
P3 Health Partners (PIII) United States $0.190B 0.00
American Well (AMWL) United States $0.144B 0.00
TruBridge (TBRG) United States $0.139B 7.46
111 (YI) China $0.112B 0.00
MSP Recovery (LIFW) United States $0.111B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.067B 0.00
Augmedix (AUGX) United States $0.060B 0.00
EUDA Health Holdings (EUDA) Singapore $0.057B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.043B 0.00
CareCloud (CCLD) United States $0.040B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Syra Health (SYRA) United States $0.011B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00